Ibolya Fábián

592 total citations · 1 hit paper
20 papers, 390 citations indexed

About

Ibolya Fábián is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Ibolya Fábián has authored 20 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Oncology. Recurrent topics in Ibolya Fábián's work include Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (4 papers) and Melanoma and MAPK Pathways (3 papers). Ibolya Fábián is often cited by papers focused on Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (4 papers) and Melanoma and MAPK Pathways (3 papers). Ibolya Fábián collaborates with scholars based in Hungary, United States and Netherlands. Ibolya Fábián's co-authors include Jenő Reiczigel, Marco Marozzi, Lajos Rózsa, György Rokszin, István Wittmann, Péter Kempler, Zoltán Kiss, György Jermendy, Zoltán Szekanecz and G Molnár and has published in prestigious journals such as Cancers, Trends in Parasitology and JACC. Cardiovascular imaging.

In The Last Decade

Ibolya Fábián

19 papers receiving 382 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biostatistics for Parasitologists – A Primer to Quantitative Parasitology

2019 284 citations Jenő Reiczigel, Marco Marozzi et al. Trends in Parasitology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ibolya Fábián Hungary	8	199	147	54	53	53	20	390
Hefin Wyn Williams United Kingdom	12	182 0.9×	119 0.8×	77 1.4×	213 4.0×	33 0.6×	25	482
Brad Lock United States	10	73 0.4×	103 0.7×	16 0.3×	69 1.3×	26 0.5×	28	377
Qing Lin China	14	98 0.5×	274 1.9×	66 1.2×	88 1.7×	22 0.4×	51	549
Andrea Gudan Kurilj Croatia	9	44 0.2×	65 0.4×	29 0.5×	59 1.1×	21 0.4×	55	245
Martha Weber United States	12	78 0.4×	69 0.5×	25 0.5×	84 1.6×	31 0.6×	25	338
Carlos Cruz Mexico	10	118 0.6×	88 0.6×	14 0.3×	10 0.2×	71 1.3×	45	439
Elizabeth Castro Moreno Brazil	13	115 0.6×	229 1.6×	50 0.9×	14 0.3×	38 0.7×	31	686
Allison D. Tuttle United States	9	70 0.4×	61 0.4×	16 0.3×	42 0.8×	24 0.5×	28	264
Carmel Witte United States	12	87 0.4×	38 0.3×	50 0.9×	69 1.3×	17 0.3×	34	410
Martina Patzl Austria	15	49 0.2×	43 0.3×	45 0.8×	107 2.0×	27 0.5×	26	568

Countries citing papers authored by Ibolya Fábián

Since Specialization

Citations

This map shows the geographic impact of Ibolya Fábián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibolya Fábián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibolya Fábián more than expected).

Fields of papers citing papers by Ibolya Fábián

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibolya Fábián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibolya Fábián. The network helps show where Ibolya Fábián may publish in the future.

Co-authorship network of co-authors of Ibolya Fábián

This figure shows the co-authorship network connecting the top 25 collaborators of Ibolya Fábián. A scholar is included among the top collaborators of Ibolya Fábián based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibolya Fábián. Ibolya Fábián is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Szilveszter, Bálint, Melinda Boussoussou, György Rokszin, et al.. (2025). Interaction Between Statin Use, Coronary Artery Disease Phenotypes, on Computed Tomography Angiography, and Cardiovascular Outcomes. JACC. Cardiovascular imaging. 18(10). 1116–1127. 1 indexed citations

Abonyi‐Tóth, Zsolt, György Rokszin, Ibolya Fábián, et al.. (2024). Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1). Cancers. 16(9). 1745–1745. 1 indexed citations

Márk, László, István Reiber, György Rokszin, et al.. (2024). A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary. Journal of Clinical Medicine. 13(21). 6562–6562. 1 indexed citations

Abonyi‐Tóth, Zsolt, György Rokszin, Gábor Sütő, et al.. (2024). Incident Cancer Risk of Patients with Prevalent Type 2 Diabetes Mellitus in Hungary (Part 2). Cancers. 16(13). 2414–2414.

Jermendy, György, György Rokszin, Ibolya Fábián, Péter Kempler, & István Wittmann. (2023). Morbidity and mortality of patients with diabetic neuropathy treated with pathogenetically oriented alpha-lipoic acid versus symptomatic pharmacotherapies – A nationwide database analysis from Hungary. Diabetes Research and Clinical Practice. 201. 110734–110734. 7 indexed citations

Sütő, Gábor, G Molnár, György Rokszin, et al.. (2023). Nátrium-glükóz kotranszporter-2 gátlóval és/vagy dipeptidilpeptidáz-4-gátlóval kezelt 2-es típusú cukorbetegségben szenvedő betegek morbiditási és mortalitási kockázata: nemzeti vizsgálat. 31(4). 237–249. 1 indexed citations

Kiss, Zoltán, György Rokszin, Ibolya Fábián, et al.. (2023). Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database. Clinical Therapeutics. 45(4). 333–346. 1 indexed citations

Jermendy, György, György Rokszin, Ibolya Fábián, Péter Kempler, & István Wittmann. (2023). Diabéteszes neuropathiában szenvedő cukorbetegek morbiditási és mortalitási adatai: alfa-liponsavval végzett oki vs. tüneti terápia összehasonlítása – hazai, országos adatbázis elemzésének eredményei. 31(6). 449–458. 1 indexed citations

Liszkay, Gabriella, Csaba Polgár, Judit Oláh, et al.. (2023). Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019. Journal of the European Academy of Dermatology and Venereology. 37(5). 932–940. 3 indexed citations

10.

Rokszin, György, Zoltán Kiss, Gábor Sütő, et al.. (2021). Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study. Frontiers in Oncology. 11. 725465–725465. 17 indexed citations

11.

Liszkay, Gabriella, Zoltán Kiss, Rolland Gyulai, et al.. (2021). Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study. Frontiers in Oncology. 10. 612459–612459. 15 indexed citations

12.

Fábián, Ibolya, et al.. (2021). Evaluation of corneal anaesthesia after the application of topical 0.5% bupivacaine, 2% lidocaine and 0.4% oxybuprocaine in normal horses. Veterinary Anaesthesia and Analgesia. 48(6). 972–976. 1 indexed citations

13.

Kiss, Zoltán, Rolland Gyulai, Judit Oláh, et al.. (2021). Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study. Frontiers in Oncology. 11. 745550–745550. 3 indexed citations

14.

Sütő, Gábor, G Molnár, György Rokszin, et al.. (2021). Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study. BMJ Open Diabetes Research & Care. 9(1). e001765–e001765. 21 indexed citations

15.

Kiss, Zoltán, György Jermendy, György Rokszin, et al.. (2021). A 2-es típusú hazai cukorbetegek többlethalálozásának nem és korcsoport szerinti értékelése. 29(3). 161–173. 1 indexed citations

16.

Géczi, Lajos, G. Bodoky, György Rokszin, Ibolya Fábián, & László Torday. (2020). Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Pathology & Oncology Research. 26(4). 2201–2207. 8 indexed citations

17.

Jermendy, György, Zoltán Kiss, György Rokszin, et al.. (2020). Changes in mortality rates and ratios in people with pharmacologically treated type 2 diabetes mellitus between 2001 and 2016 in Hungary. Diabetes Research and Clinical Practice. 163. 108134–108134. 9 indexed citations

18.

Reiczigel, Jenő, Marco Marozzi, Ibolya Fábián, & Lajos Rózsa. (2019). Biostatistics for Parasitologists – A Primer to Quantitative Parasitology. Trends in Parasitology. 35(4). 277–281. 284 indexed citations breakdown →

19.

Fábián, Ibolya, et al.. (2017). Assessment of adrenocortical reserve capacity and inflammatory parameters in critically ill dogs. Acta Veterinaria Hungarica. 65(4). 475–486. 5 indexed citations

20.

Kovács, B, M.J.M. Toussaint, E. Gruys, et al.. (2007). Evaluation of goose serum amyloid a acute phase response by enzyme-linked immunosorbent assay. Acta Veterinaria Hungarica. 55(3). 349–357. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact